Kenvue Inc. Common Stock vs Marqeta Inc — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Marqeta Inc trades at $18.09 (market cap $1.82B). The key difference: Kenvue Inc. Common Stock is far larger — about 18.7× Marqeta Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals.
| KVUE | MQ | |
|---|---|---|
Market Cap | $34.06B | $1.82B |
Volume | 23,267,228 | 1,126,466 |
Sector | Consumer Staples | Technology |
52-Week High | $19.83 | $20.32 |
52-Week Low | $14.11 | $15.04 |
Enterprise Value | $41.56B | $1.13B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 44 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Marqeta (MQ) trades at $18.11, up 6.15% with a bullish technical signal. The stock shows strong earnings momentum, beating estimates for three consecutive quarters, while revenue grew 23% year-over-year to $625M in 2025. Recent partnerships with BVNK for stablecoin cards and Google for kids' wallets highlight strategic expansion. However, valuation remains elevated with a P/E of 193.83 and negative EBITDA of -$19.27M despite improving cash flow trends.
Outlook remains mixed with analyst consensus at Hold (59% of ratings) and a $11.38 price target suggesting 37% downside. Key risks include contract renewals in Q3 2026 potentially slowing growth, while institutional sentiment is cautious despite technical strength. The stock's premium valuation requires sustained execution to justify current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →